ELBONIX 50 MG
COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
ELOPAG 25 MG
Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis
HEPANIB 200 MG
Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with
LAPANIX 250 MG
LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase
PALBOCENT 125 MG
DESCRIPTION Palbocent Palbociclib 125 mg Capsules Incepta Pharmaceuticals Limited Indications Palbociclib is a kinase inhibitor indicated for the treatment of
PALBONIX 125 MG
DESCRIPTION Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: